| Literature DB >> 24042013 |
Noémia Nhancupe1, Fernando Salazar-Anton, Emília Virginia Noormahomed, Sónia Afonso, Johan Lindh.
Abstract
Commercial antigens used to diagnose human neurocysticercosis are obtained from either a soluble parasite extract or a parasite-derived glycoprotein fraction. The aim of the present study was to identify antigenic proteins as potential diagnostic candidates in Mozambique. Soluble proteins from Taenia solium cysticerci were separated by two-dimensional electrophoresis and blotted onto nitrocellulose membranes. Subtracted hybridization was performed with serum samples obtained from patients with neurocysticercosis (NCC) and from a NCC-negative control group. Six antigenic proteins were identified and sequenced by liquid chromatography-mass spectrometry. Among these we found Tsol-p27, which was previously identified as a diagnostic candidate in a study conducted in Nicaragua, Central America. Here, we evaluated Tsol-p27 and the antigen cC1 as potential recombinant diagnostic reagents, and also investigated the localization and partial function of Tsol-p27. Immunoblotting demonstrated that Tsol-p27 was recognized by all 10 serum samples from NCC-positive individuals, whereas cC1 was identified by only five of the 10 positive sera. None of the antigens were recognized by negative control sera. Despite the limited number of serum samples evaluated in this study, the results suggest that Tsol-p27 can be a suitable candidate for diagnosis of human NCC, not only in Central America but also in sub-Saharan Africa.Entities:
Keywords: Cysticercosis; Diagnosis; Immunoreactive proteins; Serology; Taenia solium
Mesh:
Substances:
Year: 2013 PMID: 24042013 PMCID: PMC4257600 DOI: 10.1016/j.exppara.2013.09.006
Source DB: PubMed Journal: Exp Parasitol ISSN: 0014-4894 Impact factor: 2.011
Fig. 1Identification of immunoreactive proteins from T. solium cysticerci by 2-DE Western blot analysis. (A) A 2-DE gel stained with Coomassie blue, showing soluble cysticerci proteins with pI values in the range 4–7. (B) Corresponding Western blot probed with serum from a patient diagnosed with NCC. (C) Corresponding Western blot probed with serum from a control subject. Arrows indicate the proteins that were isolated and sequenced (Table 1).
Identified immunoreactive proteins recognized by NCC-positive human sera (BLAST search performed with an E-value cut-off of <10−5).
| Spot No. | Protein identity | GeneBank accession/organism | Amino acid sequence | M.W. (kDa) | pI |
|---|---|---|---|---|---|
| 1 | Tropomyosin | ABN14948.1/ | (K)AINLENQLK(E) | 32.2 | 4.7 |
| (K)NIQTEVDTVQESLQEAISK(L) | |||||
| (R)ATNAEAEVAAMTR(R) | |||||
| (R)LLEEDFEQSSGR(L) | |||||
| (R)MAQLEEQVK(E) | |||||
| (K)YIAEDAER(K) | |||||
| (R)LAVTEVDLER(A) | |||||
| (K)IVELEEELR(I) | |||||
| (K)SLEVSEQESLQR(E) | |||||
| (R)EESYEETIR(D) | |||||
| (K)LQNEVDRLEDELLSEK(E) | |||||
| 2 | Enolase | ACX56268/ | (K)LGANAILGVSLAVCK(A) | 47 | 6.2 |
| (K)LAMQEFMILPTGAK(N) | |||||
| SGETEDSTIADIVVGLR | |||||
| (K)HIADLAGNK(N) | |||||
| (K)ACNALLLK(V) | |||||
| (K)YNQLLR(I) | |||||
| (K)VNQIGSVTESIK(A) | |||||
| (R)AAVPSGASTGVHEAVELR(D) | |||||
| (K)IGMDVASSEFYQDGK(Y) | |||||
| LAEIYLEMLSK | |||||
| IEEELGSK | |||||
| 3 | Antigen cC1 | AAD34598.1/ | NLTPSTLSQVVNPGLAETDAK | 37.9 | 5.7 |
| EALLLALAGQADEPQAMQLK | |||||
| SFLQLNATNEAYNR | |||||
| YAELYGETLEAAIK | |||||
| ADTDLGSIK | |||||
| DAYPSISSK | |||||
| FALLLIQSPWQVMAEALYDAMK | |||||
| VLNEIIAGCSK | |||||
| SLVHLYAPNGEK | |||||
| TLHDALTSELSGK | |||||
| GDTSGDYEALCLK | |||||
| ASLFAELLHFAMR | |||||
| AFEEVSGGETLDDAIK | |||||
| ELYACGEGRPGTAESR | |||||
| 4 | Actin | AAA30092.1/ | (R)VAPEEHPVLLTEAPLNPK(A) | 41.7 | 5.3 |
| (R)GYSFTTTAER(E) | |||||
| (K)YPIEHAIVTNWDDMEK(I) | |||||
| (K)QEYDESGPSIVHR(K) | |||||
| (K)LCYVALDFEQEMATAASSSSLEK(S) | |||||
| (K)IWHHTFYNELR(V) | |||||
| (K)EITSLAPSTMK(I) | |||||
| (K)IVAPPER(K) | |||||
| (K)AGFAGDDAPR(A) | |||||
| (K)DSYVGDEAQSK(R) | |||||
| 5 | Heat shock Protein p36 | Q7YZT0/ | (R)NLFSLEPFTAMDNAFESVMK | 35.5 | 5.7 |
| (R)EFHPELEYTQPGELDFLK(D) | |||||
| (K)SVACGDAAMSESVGR(S) | |||||
| (K)GLAIQPSEVQER(Q) | |||||
| (R)SIPLPPSVDR(N) | |||||
| (K)VYVHGVTGK(E) | |||||
| (K)EMSAIQPR(E) | |||||
| (K)VYFNVK(N) | |||||
| 6 | Tsol-p27 | AEF14021.1/ | (R)TSDLIHEIDQMK(A) | 27 | 5.0 |
| (K)IITATEEFVDINIASK(V) | |||||
| (K)LGTALEQVASQSEK(A) | |||||
| (K)NFLNTTLSEAQK(A) | |||||
| (K)EFDGLSVQLLDLIR(A) | |||||
| (K)NYYEACAK(E) |
Fig. 2Immunoblot analysis of recombinant antigens Tsol-p27 (A and B) and cC1(C and D). (A and C) Probing done with sera (diluted 1:500) from patients diagnosed as NCC positive by CT (lanes 1–4). (B and D) Probing done with sera (diluted 1:500) from patients diagnosed as NCC negative by CT.
Fig. 3Western blot analysis of extracts of T. solium cysticerci (A) and tapeworms (B) using anti-rabbit Tsol-p27 immune sera, and pre-immune sera as negative control Probing was done with Tsol-p27 immune serum in lanes 1 and 3, and with pre-immune serum in lanes 2 and 4.
Fig. 4Sections of Taenia solium cysticerci examined by phase contrast microscopy and FITC staining. Panels A and B show (arrows) the parenchymal folds (PF) and tegument of the spiral canal (TSC). Panel B is an image obtained using rabbit anti-Tsol-p27 antibodies, and structures are indicated as in panels A and B. Panel C show the results obtained using pre-immune sera as control.